Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy
Sign Up to like & getrecommendations! Published in 2017 at "Wiener klinische Wochenschrift"
DOI: 10.1007/s00508-017-1263-2
Abstract: SummaryBackgroundPatients with a history of intravenous drug abuse included in an official opioid substitution program represent an important subgroup of patients with chronic hepatitis C. The objective of this study was to assess the efficacy of and… read more here.
Keywords: opioid substitution; substitution therapy; treatment; peginterferon ... See more keywords
Fulminant type 1 diabetes caused by peginterferon α‐2a therapy in hepatitis C
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Diabetes"
DOI: 10.1111/1753-0407.12636
Abstract: Interferon therapy can increase the risk of type 1 diabetes (T1D) in patients with hepatitis C. Fulminant T1D (FT1D) is a novel subtype of T1D characterized by extremely rapid progression. However, the relationship between interferon… read more here.
Keywords: t1d; hepatitis; dqb1; peginterferon ... See more keywords